About Michael Soumas

Michael Soumas focuses his practice on corporate securities matters, representing both domestic and foreign companies in a full range of general corporate and securities matters, with a focus on navigating the process of capital raising, including initial public offerings (IPOs), follow-on offerings, shelf takedowns, private placements in public equities (PIPEs), as well as SEC reporting and compliance and corporate governance matters.

Michael advises clients on a wide variety of securities laws and governance matters, including drafting and reviewing annual, periodic and current reports and proxy statements, compliance with SEC/stock exchange rules and board meeting minutes, as well as with respect to day-to-day operational matters, including contract review, covenant compliance and investor communications. Michael also represents banks and funds in capital markets transactions, including underwritten public offerings, at-the-market facilities, equity line programs and PIPEs. Michael works with many Israeli tech companies in a myriad of areas including life sciences, defense, tech, pharma and others.

Prior to joining Greenberg Traurig, Michael served as vice president and counsel at a global investment bank, providing legal advice on equity derivative, margin loan and structured finance transactions.

Concentrations

•Securities and capital markets
•Public and private offerings, including IPOs
•SEC reporting and corporate governance compliance
•Dual listings and American depositary facilities
•Equity line and ATM facilities
•Share exchange transactions
•Equity derivatives and margin loans
•Pharma, medical service, digital health and other life science
•Israel
•Greece

Recognition & Leadership

Awards & Accolades

Chambers Global
•Team Member, Corporate/M&A (Desk based Abroad in USA), 2022-2026
LMG Life Sciences EMEA Awards:
•Shortlisted, Israeli Firm of the Year, 2025
•Shortlisted, Corporate Rising Star, 2024
LegallyIsrael100
•Team Member, Capital Markets, 2023-2025
•Team Member M&A (Volume & Value), 2022-2025
•Team Member, Hi-Tech, 2022-2025
•Team Member, Banking & Finance, 2022-2025
Dun's 100 (Israel)
•Recognized, Capital Markets, Notable Law Firm, 2025
•Recognized, International Commercial, Prominent Team, 2022-2025
•Recognized, Hi-Tech, Notable Law Firm, 2022-2025
BDiCode
•Recognized, Commercial, Prominent Leaders, 2022-2023; 2025
•Recognized, International Commercial, Prominent Leaders, 2022-2025
•Recognized, Capital Markets, Prominent Leaders, 2024-2025
•Recognized, Hi-Tech, Prominent Leaders, 2021-2025
•IFLR1000 (Israel)
•Recognized, Capital Markets: Equity, 2024-2025

 

Reviews for Michael

This lawyer does not have any client reviews on Lawyers.com yet

Write a Review

Services

Areas of Law

  • Other 5
    • Corporate
    • Capital Markets
    • Venture Capital & Emerging Technology
    • Life Sciences & Medical Technology
    • Mergers & Acquisitions

Practice Details

  • Languages
    English
    Native; Spanish
    Conversational
  • Firm Information
    Position
    Shareholder
    Firm Name
    Greenberg Traurig, LLP
  • Representative Cases & Transactions
    Cases
    Experience: Capital Markets: Ongoing representation of several Nasdaq
    NYSE public companies.
    Represented an Israeli video optimization technology
    solutions in their initial public offering (IPO) on the Nasdaq
    follow-on public offering.
    Represented an Israel company that is a global leader in vision
    light control technologies in their IPO on the Nasdaq.
    Represented an Israeli regenerative medicine company in their IPO on the New York Stock Exchange.
    Represented an Israeli company that is a leading innovator in alternative proteins
    3D printing technologies in multiple transactions, including a follow-on public offering of American Depositary Shares
    warrants, warrant inducement transaction, private investment in public equity (PIPE), equity line facility, at-the-market sale (ATM) facility.
    Represented an Israeli-based company which develops systems for the prevention of strokes in multiple transactions, including PIPEs
    ATM facility.
    Represented an Israeli technology company that seeks to revolutionize railway safety
    the data-related market in multiple transactions, including a PIPE, equity line facility, ATM facility
    convertible loan facility.
    Represented an Israeli technology company that develops
    commercializes advanced transportation safety solutions in establishing an equity line facility.
    Represented an Israeli aerospace defense company pioneering smart, autonomous solutions for the global manned
    unmanned aerial systems (UAS) industry in multiple transactions, including IPO on the Nasdaq, a PIPE
    registered direct offerings.
    Represented an Israeli-based technology company that is a global leader in AI-powered fashion technology
    overstock management solutions in multiple transactions, including a warrant inducement transaction, ATM facility
    registered direct offering.
    Represented an Israeli company that is a global leader in connected home ultrasound technology in the dual listing of its ordinary shares on the Nasdaq.
    Represented an Israeli-based advanced technology company in multiple transactions, including the uplisting of its common stock to the Nasdaq, PIPEs
    convertible loan facility.
    Represented an Israeli-based biotech company in multiple transactions, including the uplisting of its common shares to Nasdaq, registered direct offerings
    convertible loan facility.
    Represented an Israeli biotechnology company in multiple transactions, including their IPO on the Nasdaq
    PIPE.
    Represented an Israeli-based company that is a provider of cybersecurity
    robust solutions for drones
    robotics in multiple transactions, including its registered direct offering
    ATM facility.
    Represented an Israeli-based company that is a leader in AI-powered visual sensing technologies in the uplisting of its common stock to the Nasdaq.
    Represented an Israel late-clinical stage biotechnology company in multiple transactions, including registered direct offering, PIPE, ATM facility
    equity line facility.
    Represented an Israeli clinical-stage biopharmaceutical company in multiple transactions, including follow-on public offering, equity line facility, ATM facility
    establishment of a digital asset management strategy.
    Represented an Israeli biotechnology company that is listed on the New York Stock Exchange on multiple transactions, including registered direct offerings, follow-on public offering, warrant inducement transactions
    ATM facility.
    Represented an Israeli-based clinical stage biotechnology company in multiple transactions, including follow-on public offerings, warrant inducement transactions
    ATM facility.
    Represented purchasers in connection with equity line programs.
    Represented investment banks in connection with underwritten public offerings, PIPEs
    ATM programs.
    Corporate
    M & A
    Represented an Israeli-based advanced technologies company in its strategic acquisition in a share exchange transaction of up to 100% of the share capital of an Israeli company that is engaged in developing
    promoting quantum algorithms for the transportation, drug discovery
    security segments as well as developing quantum-based GPS replacement
    quantum atom accuracy solutions.
    Represented an Israeli-based technology company in its strategic acquisition in a share exchange transaction of approximately 30% of the share capital of an Israeli company that designed
    manufactures micro-mobility solutions, supporting its continued growth
    market-expansion strategy.
    Represented an Israeli-based technology company that is a global leader in AI-powered fashion technology
    overstock management solutions in its strategic acquisition in a share exchange transaction of 100% of the share capital of a Spanish technology company that is engaged in delivering size
    fit solutions for every stage of the fashion industry's value chain.
    Represented an Israeli-based technology company that is a global leader in AI-powered fashion technology
    overstock management solutions in its strategic acquisition in a share exchange transaction of 100% of the share capital of a European SaaS company specializing in AI-powered footwear sizing
    fit solutions.
    Represented an Israeli-based advanced technologies company in its strategic acquisition in a share exchange transaction of up to 100% of the share capital of an Israeli company that specializes in developing advanced writing assistance tools that leverage artificial intelligence (AI), machine learning (ML),
    natural language processing (NLP) technologies.
    Represented an Israeli technology company that seeks to revolutionize railway safety
    the data-related market in its strategic acquisition in a share exchange transaction of 51% of the share capital of an Israeli a cutting-edge quantum computing
    AI company.
    In-House Experience: Vice President
    Counsel, Credit Suisse Securities (USA) LLC, 2014-2022
  • Additional Links

Experience

  • Bar Admission & Memberships
    Admissions
    2016, New York
  • Education & Certifications
    Law School
    New York Law School
    J.D.
    cum laude; Staff Editor, New York Law School Law Review; John Marshall Harlan Scholar, affiliated with the Center for Business and Financial Law
    Other Education
    Pennsylvania State University
    B.A.S.
    Economics
Case type is required.
I am is required.
First name is required.
Last name is required.
A valid zip code is required.
Country is required.
State is required.
A valid city is required.
A valid email address is required.
A valid phone number is required.
Message is required.
0/1000 characters

By clicking the Submit button, you agree to the Terms of Use, Supplemental Terms and Privacy Policy. You also consent to be contacted at the phone number you provided, including by autodials, text messages and/or pre-recorded calls, from Lawyers.com and its affiliates and from or on behalf of attorneys you request or contact through this site. Consent is not a condition of purchase.

You should not send any sensitive or confidential information through this site. Emails sent through this site do not create an attorney-client relationship and may not be treated as privileged or confidential. The lawyer or law firm you are contacting is not required to, and may choose not to, accept you as a client. The internet is not necessarily secure and emails sent though this site could be intercepted or read by third parties.

This site is protected by reCAPTCHA. See Google’s Privacy Policy and Terms of Service.

Thank you! Your message has been successfully sent.

For your records, a copy of this email has been sent to test@test.com.

Summary of Your Message
Case Type:
I am a/an:
First Name:
Last Name:
City:
Zip Code or Postal Code:
State:
Country:
Phone Number:
Message:

Attorneys FAQs

  • What year was this attorney first admitted to the bar?
    Michael Soumas was admitted in 2016 to the State of New York.
  • How many attorneys are in this law firm?
    Greenberg Traurig, LLP has 2750 attorneys at this location.
  • What law school did this attorney attend?
    Michael Soumas attended New York Law School.
  • What year was this attorney's law firm established?
    Greenberg Traurig, LLP was established in 1967.